Amylyx May Pull FDA-Approved ALS Drug
Disappointing phase 3 trial results of a drug approved for the treatment of amyotrophic lateral sclerosis (ALS) may prompt the ...
Read moreDisappointing phase 3 trial results of a drug approved for the treatment of amyotrophic lateral sclerosis (ALS) may prompt the ...
Read moreTaking the edge off — Injections over several months allowed people to tolerate larger doses of trigger foods. Beth Mole ...
Read more© 2023 earth-news.info